TVM IV

TVM Capital Life Science is a prominent international venture capital firm specializing in the life sciences sector, including biopharmaceuticals, diagnostics, and medical technology. The firm is widely recognized for its innovative 'Project-Focused Company' (PFC) investment model, which involves creating and funding single-asset companies to develop early-stage therapeutic candidates through to clinical proof-of-concept, often in collaboration with strategic partners like Eli Lilly and Company. TVM IV refers to one of the firm's earlier funds, TVM IV GmbH & Co. KG, which was a significant investor in several successful biotech companies such as Enanta Pharmaceuticals, MorphoSys, and Definiens. With a presence in Munich and Montreal, the firm manages a diverse portfolio and continues to drive innovation in drug development through its unique investment strategies and strategic pharmaceutical partnerships.